Lv4
550 积分 2025-05-06 加入
Estimate of the cost per responder for treatment with biological therapies of moderate-to-severe plaque psoriasis in Colombia for first-year and maintenance periods
5个月前
已完结
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review
5个月前
已完结
Cycling to TNFi vs. Switching to IL-17Ai Among Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Real-World CorEvitas PsA/SpA Registry Data
5个月前
已完结
Association of aging and the risk of late-onset psoriasis: Evidence from the UK Biobank cohort
6个月前
已完结
Effect of the age of onset on epidemiology, clinical features, and comorbidity of geriatric psoriasis
7个月前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
7个月前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
7个月前
已完结
Age of Onset Matters: Tildrakizumab Response in Early vs Late-Onset Psoriasis
7个月前
已完结
Infection and infestation-related adverse events of biologics in psoriasis: insights from the Food and Drug Administration Adverse Event Reporting System (FAERS)
7个月前
已完结
Rapid and sustained resolution in generalized pustular psoriasis with IL‐17A inhibitors required high adherence: a 96‐week analysis in a real‐life setting
8个月前
已完结
皖公网安备34019202002308
